ABUNDANCE of A NATURAL ODOUR in HUMAN CEREBROSPINAL FLUID AFTER OLFACTORY EXPOSURE - the OLFO-Brain Study

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity Hospital, Basel, Switzerland

About this trial

The goal of this clinical trial is to investigate the abundance of a natural odour in human cerebrospinal fluid in obese and lean participants after inhalation thereof. Participants will undergo blood sample collection and inhalation of either a natural odour or placebo through an inhaler in addition to a liquor puncture prescribed in standard of care context.

Eligibility criteria

Qualifiers

Age 18-60 years

Written informed consent

Scheduled for routine liquor puncture

BMI ≥ 30 kg/m2

Disqualifiers

Known allergy to the natural odour

Acute upper respiratory tract infection, acute or chronic sinusitis

Present or past surgical intervention of the nasal cavity, the paranasal sinus, the pituitary or the frontal brain

Pregnancy/lactation

Trial design

Treatments tested in this trial

  • Inhalation - Natural Odour
  • Inhalation - Placebo

Treatment groups

32 Participants
are divided into 2 treatment groups